0001104659-15-026765.txt : 20150409
0001104659-15-026765.hdr.sgml : 20150409
20150409164436
ACCESSION NUMBER: 0001104659-15-026765
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150407
FILED AS OF DATE: 20150409
DATE AS OF CHANGE: 20150409
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mylan N.V.
CENTRAL INDEX KEY: 0001623613
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981189497
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ALBANY GATE, DARKES LANE
CITY: POTTERS BAR, HERTS
STATE: X0
ZIP: EN6 1AG
BUSINESS PHONE: 44 0 1707 853 000
MAIL ADDRESS:
STREET 1: ALBANY GATE, DARKES LANE
CITY: POTTERS BAR, HERTS
STATE: X0
ZIP: EN6 1AG
FORMER COMPANY:
FORMER CONFORMED NAME: New Moon B.V.
DATE OF NAME CHANGE: 20141028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abbott Investments Luxembourg S.A R.L.
CENTRAL INDEX KEY: 0001635614
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 15761817
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
BUSINESS PHONE: 224-668-3591
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abbott Established Products Holdings Gibraltar Ltd
CENTRAL INDEX KEY: 0001635611
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 15761818
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
BUSINESS PHONE: 224-668-3591
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 15761819
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: D-322 AP6D
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 8479376100
4
1
a4.xml
4
X0306
4
2015-04-07
0
0001623613
Mylan N.V.
MYL
0000001800
ABBOTT LABORATORIES
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6092
0
0
1
0
0001635611
Abbott Established Products Holdings Gibraltar Ltd
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6092
0
0
1
0
0001635614
Abbott Investments Luxembourg S.A R.L.
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6092
0
0
1
0
Ordinary Shares, nominal value Euro 0.01 per share
2015-04-07
4
X
0
5250000
56.8912
D
69750000
I
By Subsidiaries
Call Option (Obligation to Sell)
56.8912
2015-04-07
4
X
0
1
0
D
2015-03-31
2015-04-30
Ordinary Shares
5250000
0
I
By Subsidiaries
(1) The Ordinary Shares of Mylan N.V. ("Mylan") described in this report are held directly by Abbott Established Products Holdings (Gibraltar) Limited and Abbott Investments Luxembourg S.a r.l (collectively, the "Subsidiaries"). Each of the Subsidiaries is an indirect, wholly-owned subsidiary of Abbott Laboratories ("Abbott"). In Abbott's capacity as the ultimate corporate parent of the Subsidiaries, Abbott may be deemed to indirectly beneficially own such Ordinary Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Securities and Exchange Commission thereunder. (2) On March 31, 2015, the Subsidiaries and Laboratoires Fournier S.A.S., an indirect, wholly-owned subsidiary of Abbott, entered into an Underwriting Agreement (the "Underwriting Agreement") with Morgan Stanley & Co. LLC and Goldman Sachs & Co., as representatives of the several underwriters named therein, and Mylan relating to an underwritten public resale offering an aggregate of 35,000,000 Ordinary Shares. The offering transaction closed on April 6, 2015. Pursuant to the Underwriting Agreement, Abbott Investments Luxembourg S.a r.l, for no additional consideration, granted the underwriters a 30-day option to purchase up to an additional 5,250,000 Ordinary Shares for a purchase price of $56.89125 per Ordinary Share. On April 7, 2015, the representatives of the underwriters exercised the foregoing option in full.
Thomas C. Freyman
2015-04-09